Medicamen Biotech Limited (NSE:MEDICAMEQ)
India · Delayed Price · Currency is INR 275.00
-4.55 (-1.63%)
Nov 11, 2026, 2:12 PM IST
Medicamen Biotech Market Cap
Medicamen Biotech has a market cap or net worth of 3.71 billion as of November 10, 2026. Its market cap has decreased by 27.20% in one year.
Market Cap
3.71B
Enterprise Value
3.87B
Revenue
2.06B
Global Rank
n/a
Country Rank
n/a
PE Ratio
36.91
ChartMarket Cap Chart
Since January 12, 2005, Medicamen Biotech's market cap has increased from 108.49M to 3.71B, an increase of 3,318.87%. That is a compound annual growth rate of 17.55%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 11, 2026 | 3.71B | -19.65% |
| Dec 31, 2025 | 4.62B | -28.94% |
| Dec 31, 2024 | 6.50B | -14.77% |
| Dec 29, 2023 | 7.62B | -27.09% |
| Dec 30, 2022 | 10.45B | -3.50% |
| Dec 31, 2021 | 10.83B | 86.37% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Jagsonpal Pharmaceuticals | 14.36B |
| Anlon Healthcare | 14.31B |
| Bafna Pharmaceuticals | 11.18B |
| Sigachi Industries | 10.37B |
| Amanta Healthcare | 7.85B |
| Valiant Laboratories | 6.06B |
| Nectar Lifesciences | 1.99B |
| Brooks Laboratories | 1.94B |